Company intelligence / Profile preview

Polaris Quantum Biotech

Durham, North Carolina, United Statesfujitsu.com ↗

Ownership: Private
Development stage: Preclinical

Overview

The company uses quantum computing, AI, and machine learning to identify drug lead molecules 10,000 times faster than alternative solutions. Their platform can search a chemical space of up to 10^23 molecules to find optimal candidates.

Therapeutic areas: OtherWomen's Health
Modalities: Small molecules
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Polaris Quantum Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Polaris Quantum Biotech.

Explore the full profile